SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Wiley John & Sons, Inc. – ‘8-K’ for 3/2/05

On:  Wednesday, 3/2/05, at 9:29am ET   ·   For:  3/2/05   ·   Accession #:  107140-5-9   ·   File #:  1-11507

Previous ‘8-K’:  ‘8-K’ on / for 1/19/05   ·   Next:  ‘8-K’ on 3/3/05 for 1/31/05   ·   Latest:  ‘8-K’ on / for 8/4/17

  in   Show  and 
Help... Wildcards:  ? (any letter),  * (many).  Logic:  for Docs:  & (and),  | (or);  for Text:  | (anywhere),  "(&)" (near).    Bottom
 
  As Of                Filer                Filing    For·On·As Docs:Size

 3/02/05  Wiley John & Sons, Inc.           8-K:5       3/02/05    1:4K

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         McKinnell Retirement From Board                        3      9K 


Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
2Item 5.02. Departure of Directors or Principal Officers
8-K1st Page of 3TOCTopPreviousNextBottomJust 1st
 

SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 March 2, 2005 (Date of Report) (Date of earliest event reported) JOHN WILEY & SONS, INC. (Exact name of registrant as specified in its charter) New York (State or jurisdiction of incorporation) 0-11507 13-5593032 -------------------------------------- ---------------------------------- Commission File Number IRS Employer Identification Number 111 River Street, Hoboken NJ 07030 -------------------------------------- ---------------------------------- Address of principal executive offices Zip Code Registrant's telephone number, including area code: (201) 748-6000 -------------- Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [ ] Written communications pursuant to Rule 425 under the Securities Act(17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act(17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act(17 CFR 240.13e-4(c)) NOT APPLICABLE This is the first page of a three-page document.
8-K2nd Page of 3TOC1stPreviousNextBottomJust 2nd
Item 5.02 Departure of Directors or Principal Officers -------------------------------------------- On March 2, 2005, John Wiley and Sons, Inc ("the Company") announced that Henry A. McKinnell, a non-executive director, has chosen not to stand for re-election to the Board at the Annual Meeting of Shareholders on September 15, 2005, but will serve out his term until then. Dr. McKinnell, who is Chairman of the Board and Chief Executive Officer of Pfizer, Inc., has served on the Company's Board since 1996 and has been Chairman of the Compensation Committee since September 2000. The Company is initiating a search for Dr. McKinnell's replacement.
8-KLast Page of 3TOC1stPreviousNextBottomJust 3rd
Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. John Wiley & Sons, Inc. /S/ William J. Pesce --------------------------------- William J. Pesce President and Chief Executive Officer

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘8-K’ Filing    Date First  Last      Other Filings
9/15/0524,  DEF 14A
Filed on / For Period End:3/2/0512
 List all Filings 
Top
Filing Submission 0000107140-05-000009   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2017 Fran Finnegan & Company.  All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed, 16 Aug 17:32:56.0 GMT